Delivery Order SPE2DB20D2104-SPE2DB23FV08C

Award Date 8/28/23
Potential Completion Date 8/29/23
Potential Value $28
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Logistics Agency awarded a firm fixed price delivery order valued at thirty-eight thousand two dollars to Amerisourcebergen Drug Corporation for one hundred tablets of phentermine hydrochloride 37.5 mg. As the parent company of Amerisourcebergen Drug Corporation, Amerisourcebergen Corporation will perform under the contract from its location in Conshohocken, Pennsylvania. The delivery order was issued against an existing DLA contract vehicle to supply pharmaceutical products and...
The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $49,360 to Amerisourcebergen Drug Corporation for the supply of 100 capsules of phentermine hydrochloride 37.5 mg. As the parent company of Amerisourcebergen Drug Corporation, Amerisourcebergen Corporation will perform under the contract from its facility in Conshohocken, Pennsylvania. The delivery order was issued against an existing DLA contract vehicle and requires that the pharmaceutical products be delivered by...
The Defense Logistics Agency awarded a firm fixed price delivery order valued at $24,680 to Amerisourcebergen Drug Corporation for the supply of 100 capsules of phentermine hydrochloride 37.5 mg. As the parent company of Amerisourcebergen Drug Corporation, Amerisourcebergen Corporation will perform under the contract from its location in Conshohocken, Pennsylvania. The single day delivery order was issued on July 6, 2023 to fulfill requirements under an existing DLA pharmaceuticals contract...
The Defense Logistics Agency awarded a firm fixed price delivery order valued at thirty-eight thousand two dollars to Amerisourcebergen Drug Corporation for the supply of one hundred tablets of phentermine hydrochloride 37.5 mg. As the prime contractor, Amerisourcebergen Drug Corporation will deliver the pharmaceutical products to a location in Conshohocken, Pennsylvania by September 20, 2023 under the terms of the order. The Defense Logistics Agency is the funding agency for this requirement in...
The Defense Logistics Agency awarded a firm fixed price delivery order valued at one hundred seventeen thousand one hundred eighteen dollars to Amerisourcebergen Drug Corporation. The order is for one thousand tablets of phentermine hydrochloride 37.5 mg to be delivered to a facility in Conshohocken, Pennsylvania by September 26, 2023. Amerisourcebergen Corporation is the parent company of Amerisourcebergen Drug Corporation, which will perform under the contract. The Defense Logistics Agency...
The Defense Logistics Agency awarded a firm fixed price delivery order valued at $61,700 to Amerisourcebergen Drug Corporation for the supply of 100 capsules of phentermine hydrochloride, 37.5 mg each. As the prime contractor, Amerisourcebergen Drug Corporation will deliver the pharmaceutical products to a location in Conshohocken, Pennsylvania by September 28, 2023 under the terms of the order. The parent company, Amerisourcebergen Corporation, will perform through its Amerisourcebergen...
The Defense Logistics Agency awarded a firm fixed price delivery order valued at $17,700 to Amerisourcebergen Drug Corporation for 100 tablets of phentermine hydrochloride 37.5 mg. As the parent company of Amerisourcebergen Drug Corporation, Amerisourcebergen Corporation will perform the contract through its Conshohocken, Pennsylvania location. The delivery order is associated with the Defense Logistics Agency's indefinite-delivery/indefinite-quantity pharmaceuticals prime vendor contract and...
The Defense Logistics Agency awarded a $575.68 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 30 capsules of phentermine hydrochloride 37.5 mg under contract number 4562053794. The single day order is being fulfilled on September 5-6, 2023 from Amerisourcebergen's facility in Conshohocken, Pennsylvania to support the Department of Defense's medical supply needs. As a top pharmaceutical distributor, Amerisourcebergen routinely provides pharmaceuticals and medical...
The Defense Logistics Agency awarded a firm fixed price delivery order valued at fifty-nine thousand dollars to Amerisourcebergen Drug Corporation. The order is for one hundred tablets of phentermine hydrochloride 37.5 mg to be delivered to a facility in Conshohocken, Pennsylvania by August 23, 2023. Amerisourcebergen Corporation is the parent company of Amerisourcebergen Drug Corporation, which will serve as the prime contractor in fulfilling this order placed under an existing DLA contract...
The Defense Logistics Agency awarded a firm fixed price delivery order valued at $61,700 to Amerisourcebergen Drug Corporation for the supply of 100 capsules of phentermine hydrochloride 37.5 mg. The place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The period of performance is September 25 through September 26, 2023. As the prime contractor, Amerisourcebergen Drug Corporation will deliver the requested pharmaceutical products to the Defense...
  • SPE2DB20D2104
    Indefinite Delivery Contract
  • SPE2DB20D2104-SPE2DB23FV08C
    Delivery Order

The Defense Logistics Agency awarded a firm fixed price delivery order valued at twenty-seven thousand eight hundred seventy-seven dollars to Amerisourcebergen Drug Corporation for one hundred capsules of phentermine hydrochloride, 37.5 milligrams each. As the parent company of Amerisourcebergen Drug Corporation, Amerisourcebergen Corporation will perform under the contract from its location in Conshohocken, Pennsylvania. The single day delivery order was issued under an existing DLA contract vehicle to supply this pharmaceutical product in support of DOD health programs from August 28 to August 29, 2023.

Generated 12/19/23, 3:24 AM